PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Pulmonary Therapy3 citationsOpen Access

Long-Term Adherence to Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis

CHCarina M. E. HansenBZBadr ZendakyAZAnnelies M. Zwitserloot

Key Points

  • To evaluate long-term adherence to Elexacaftor/Tezacaftor/Ivacaftor (ETI) and Ivacaftor (IVA) in patients with cystic fibrosis.
  • Analyzed pharmacy refill data over three years
  • Monitored adherence to ETI and IVA
  • Calculated adherence rates at multiple time points
  • High adherence to ETI and IVA observed initially
  • Adherence levels declined over the three-year period
  • Refill data indicated consistent patterns of medication usage

Abstract

Three-year adherence to ETI and IVA based on pharmacy refill data was high, yet declined over time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hansen et al. (2026) studied this question.

synapsesocial.com/papers/69b4fc44b39f7826a300d131https://doi.org/10.1007/s41030-026-00351-4
Ask AI
Helpful
Bookmark
Share
View Full Paper